TVM Capital
Early stage fund focused on life sciences companies with a project-based approach in partnership with Eli Lilly as well as traditional later-stage companies, including an allocation for diagnostic companies in partnership with Qiagen
Stade d'investissement: Early
Uncorrelated Ventures
US based seed stage venture capital firm investing primarily in infrastructure software companies
Versant Ventures
Californian venture firm operating incubators in Canada and investing through self-sustaining drug development units
Versant Ventures Voyageurs
Canada-focused fund investing alongside Versant Ventures’ primary biotech funds and targeting seed, de novo and early-stage Canadian biotechnology companies
Northern Biologics
Northern Biologics’ mission is to develop first-in-class antibody therapeutics for oncology
First Ascent Ventures
Fund dedicated to enterprise applications investing primarily in emerging Canadian technology companies
Genesys Capital
Toronto & Montreal based early stage life sciences fund focused on building companies in the high-growth sectors of healthcare and biotechnology
Golden Ventures
Seed-stage, sector agnostic fund based in Toronto which invests in category-defining companies across North America
Idinvest Partners
Pan-European fund targeting Series A/Series B investments in sectors such as fintech, digital health, gaming, e-commerce, cybersecurity, IoT, artificial intelligence, VR/AR, blockchain and mobility
Information Venture Partners
Early stage fund investing in the emerging fintech sector and related enterprise software